Business Description
Whanin Pharm Co Ltd
ISIN : KR7016580003
Compare
Compare
Traded in other countries / regions
016580.Korea IPO Date
1996-07-01Description
Whanin Pharm Co Ltd is a pharmaceutical company. The company develops, manufactures, markets, and sells the therapeutic products. It offers antibiotics, cardiovascular drugs, CNS stimulants, gastrointestinal drugs, multivitamins and other products. The company's products include Antiasthmatics; Antidepressants; Antipsychotics; Anxiolytics and hypnotics; and Antiepileptics.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 124.14 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 1331.67 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 5.62 | |||||
| Beneish M-Score | -2.34 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 10.3 | |||||
| 3-Year EBITDA Growth Rate | 4.8 | |||||
| 3-Year EPS without NRI Growth Rate | 9.8 | |||||
| 3-Year Book Growth Rate | 6.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 67.78 | |||||
| 9-Day RSI | 64.19 | |||||
| 14-Day RSI | 57.8 | |||||
| 12-1 Month Momentum % | -12.06 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.3 | |||||
| Quick Ratio | 3.95 | |||||
| Cash Ratio | 1.96 | |||||
| Days Inventory | 130.31 | |||||
| Days Sales Outstanding | 114.03 | |||||
| Days Payable | 46.53 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.09 | |||||
| Dividend Payout Ratio | 0.15 | |||||
| Forward Dividend Yield % | 2.09 | |||||
| 5-Year Yield-on-Cost % | 2.08 | |||||
| Shareholder Yield % | 2.01 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 43.04 | |||||
| Operating Margin % | 13.1 | |||||
| Net Margin % | 12.92 | |||||
| FCF Margin % | -3.6 | |||||
| ROE % | 8.64 | |||||
| ROA % | 7.71 | |||||
| ROIC % | 9.75 | |||||
| ROC (Joel Greenblatt) % | 16.78 | |||||
| ROCE % | 9.7 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 7.36 | |||||
| PE Ratio without NRI | 7.3 | |||||
| Shiller PE Ratio | 8.65 | |||||
| Price-to-Owner-Earnings | 61.27 | |||||
| PEG Ratio | 1.43 | |||||
| PS Ratio | 0.95 | |||||
| PB Ratio | 0.61 | |||||
| Price-to-Tangible-Book | 0.62 | |||||
| Price-to-Operating-Cash-Flow | 9.46 | |||||
| EV-to-EBIT | 4.18 | |||||
| EV-to-EBITDA | 3.49 | |||||
| EV-to-Revenue | 0.62 | |||||
| EV-to-FCF | -17.09 | |||||
| Price-to-Projected-FCF | 0.66 | |||||
| Price-to-DCF (Earnings Based) | 0.58 | |||||
| Price-to-Median-PS-Value | 0.56 | |||||
| Price-to-Graham-Number | 0.45 | |||||
| Price-to-Net-Current-Asset-Value | 1.3 | |||||
| Price-to-Net-Cash | 6.19 | |||||
| Earnings Yield (Greenblatt) % | 23.92 | |||||
| FCF Yield % | -3.79 | |||||
| Forward Rate of Return (Yacktman) % | 4.47 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Whanin Pharm Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 230,393.578 | ||
| EPS (TTM) (â‚©) | 1950 | ||
| Beta | 0.35 | ||
| Volatility % | 19.03 | ||
| 14-Day RSI | 57.8 | ||
| 14-Day ATR (â‚©) | 206.011657 | ||
| 20-Day SMA (â‚©) | 14011 | ||
| 12-1 Month Momentum % | -12.06 | ||
| 52-Week Range (â‚©) | 12410 - 16270 | ||
| Shares Outstanding (Mil) | 15.27 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Whanin Pharm Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Whanin Pharm Co Ltd Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Whanin Pharm Co Ltd Frequently Asked Questions
What is Whanin Pharm Co Ltd(XKRX:016580)'s stock price today?
The current price of XKRX:016580 is â‚©14360.00. The 52 week high of XKRX:016580 is â‚©16270.00 and 52 week low is â‚©12410.00.
When is next earnings date of Whanin Pharm Co Ltd(XKRX:016580)?
The next earnings date of Whanin Pharm Co Ltd(XKRX:016580) is .
Does Whanin Pharm Co Ltd(XKRX:016580) pay dividends? If so, how much?
The Dividend Yield %  of Whanin Pharm Co Ltd(XKRX:016580) is 2.09% (As of Today), Highest Dividend Payout Ratio of Whanin Pharm Co Ltd(XKRX:016580) was 0.24. The lowest was 0.15. And the median was 0.19. The  Forward Dividend Yield % of Whanin Pharm Co Ltd(XKRX:016580) is 2.09%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers